BAX vs RMD · rev $5.66B vs P/E 29, rev $5.65B
Baxter International Inc (BAX) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Baxter International Inc (BAX) is a medical instruments & supplies company listed on NYSE.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported BAX revenue for 2026-06-30 was $5.66B. Net income was $111.0M. BAX currently screens at market cap $10.01B.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
BAX currently screens at market cap $10.01B. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the BAX and RMD stock pages for the full models.
Not investment advice.